Iterum Therapeutics (ITRM) Projected to Post Earnings on Friday

Iterum Therapeutics (NASDAQ:ITRM) is anticipated to announce its earnings results before the market opens on Friday, February 7th. Analysts expect the company to announce earnings of ($0.26) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Iterum Therapeutics Stock Up 0.6 %

Shares of NASDAQ ITRM opened at $1.55 on Wednesday. The company has a market cap of $42.66 million, a P/E ratio of -0.78 and a beta of 2.28. Iterum Therapeutics has a 52 week low of $0.81 and a 52 week high of $3.02. The business has a 50-day simple moving average of $1.84 and a two-hundred day simple moving average of $1.43.

Iterum Therapeutics Company Profile

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections.